Aprea Therapeutics, Inc. Annual Operating Lease, Payments in USD from 2019 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Aprea Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2022.
  • Aprea Therapeutics, Inc. Operating Lease, Payments for the quarter ending December 31, 2022 was $53.4K, a 16.6% decline year-over-year.
  • Aprea Therapeutics, Inc. Operating Lease, Payments for the twelve months ending December 31, 2022 was $246K, a 3.72% decline year-over-year.
  • Aprea Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $246K, a 3.72% decline from 2021.
  • Aprea Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $255K, a 1.37% increase from 2020.
  • Aprea Therapeutics, Inc. annual Operating Lease, Payments for 2020 was $252K, a 43.9% increase from 2019.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $246K -$9.49K -3.72% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 $255K +$3.44K +1.37% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-26
2020 $252K +$76.8K +43.9% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-30
2019 $175K Jan 1, 2019 Dec 31, 2019 10-K 2022-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.